JPMORGAN CHASE & CO - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260862. A total of 53 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2023$173,000
+910426.3%
293,036
+490.1%
0.00%
Q4 2022$19
-98.1%
49,656
+2123.7%
0.00%
Q3 2022$1,0002,233
+1591.7%
0.00%
Q2 2022$01320.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,100,419$650,4580.10%
Virtu Financial LLC 58,883$350.00%
Simplicity Solutions, LLC 36,670$21,6760.00%
Renaissance Technologies 1,222,424$7230.00%
JPMORGAN CHASE & CO 293,036$173,0000.00%
COMMONWEALTH EQUITY SERVICES, LLC 38,359$220.00%
Gradient Investments LLC 63$370.00%
VANGUARD GROUP INC 2,427,778$1,435,0600.00%
Advisory Services Network, LLC 1$10.00%
Focused Wealth Management, Inc 222$1310.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders